This past weekend, 17 of the leading researchers in the diabetes community traveled to San Diego, CA, to speak at TEDxDelMar, an exciting day-long conference focused on the latest breakthroughs and continuing challenges in the search for a cure. Although the cure was the main focus of the day, TEDxDelMar also featured discussions on living well with diabetes (with talks including Dr. Steve Edelman and Dr. Bill Polonsky) and the future of diabetes technology (with…Read more »
Lots of organizations are working on new ways to accomplish islet cell transplantation in which the immune system does not kill off the transplanted cells. If they could do that, we’d likely have a cure for diabetes. But it ain’t easy, especially because we’re talking about transplanting into people whose immune systems are in mega-attack mode to begin with (type 1 diabetics).
The Diabetes Research Institute (DRI) in Florida is currently working on this challenge…
It’s no surprise to our readers that one of the biggest issues with current diabetes management is the lag time of our current fast-acting insulins.
Although light years ahead of what patients had in the past, current fast-acting insulins still aren’t quite up to snuff to handle post-prandial spikes. This is becomes a barrier for developing an Artificial Pancreas, as the insulin can’t respond quickly enough to sensor data in a closed-loop system.
The annual ADA Scientific Sessions conference is always kind of a mind-blower. It brings together 13,000 scientists, physicians, and other health care professionals (and now, bloggers!) from around the world.
This year, there will be hundreds of symposia, 59 special lectures, nearly 378 abstracts presented, and also nearly 2,000 research posters unveiled. Whew!
Thankfully, the ADA helps out bloggers and the media with a summary called “Clues to the News.” Here is our take on…
The Pancreum closed loop (automated insulin + CGM + glucagon) system that won a Grand Prize in the DiabetesMine Design Challenge this year may look like a pipe dream, but designer Gil DePaula assures us it is “visionary but real.”
Have a look at the video, below, and also Gil’s company website.
“The glucagon part is definitely a futuristic concept — because there’s no predicate device for glucagon delivery with the FDA, so that’s a…Read more »